---
schema_version: "secwatch.filing_event.v1"
accession: "0001516551-25-000002"
form_type: "8-K"
ticker: "SKYE"
cik: "0001516551"
company_name: "Skye Bioscience, Inc."
filed_at: "2025-02-26T23:59:59+00:00"
generated_at: "2026-05-26T03:31:03.618071+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Skye Bioscience board approves amended inducement equity plan with broader change-in-control authority

## Summary
- Amendment gives administrator broader authority to cancel, assume, accelerate, or cash out outstanding awards upon a Change in Control.
- Total shares authorized under the plan remain 600,000; no change to share pool.
- Plan is used for inducement grants to new employees; all awards must be approved by a majority of independent directors.

## SEC filing metadata
- accession: 0001516551-25-000002
- form_type: 8-K
- ticker: SKYE
- cik: 0001516551
- company_name: Skye Bioscience, Inc.
- filed_at: 2025-02-26T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1516551/000151655125000002/0001516551-25-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1516551/000151655125000002/skye-20250224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001516551-25-000002
- JSON: https://secwatch.observer/filing/0001516551-25-000002.json
- Plain text: https://secwatch.observer/filing/0001516551-25-000002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.